9780774833844_cover Enlarge Cover
0 of 5
0 ratings
list price: $39.95
also available: eBook
category: Social Science
published: July 2017
publisher: UBC Press

Health Advocacy, Inc.

How Pharmaceutical Funding Changed the Breast Cancer Movement

by Sharon Batt

tagged: disease & health issues, cancer, fundraising & grants

Health activist, scholar, award-winning journalist, and cancer survivor Sharon Batt investigates the relationship between patient advocacy groups and the pharmaceutical industry, as well as the contentious role of pharma funding. Over the past several decades, a gradual reduction in state funding has pressured patient groups into forming private-sector partnerships. This analysis of Canada’s breast cancer movement from 1990 to 2010 argues that the resulting power imbalance undermined the groups’ ability to put patients’ interests ahead of those of the funders. A movement that once encouraged democratic participation in the development of health policy now eerily echoes the demands of the pharmaceutical industry.

About the Author

Sharon Batt

Contributor Notes

Sharon Batt is an independent scholar and adjunct professor in the Department of Bioethics at Dalhousie University.

Editorial Reviews

Batt’s revelations about the relationship between patient advocacy groups and the pharmaceutical industry are vital and disturbing.

— Maisonneuve

[Batt’s] scholarly style might be a challenge for the casual reader, but those who persevere are rewarded with coverage of both sides of the debate ... Batt’s goal is to start a conversation and encourage discussion. She readily achieves this effect, and any cancer charity currently facing a funding dilemma would be well served by her book.

— Lancet Oncology
Contacting facebook
Please wait...